Follow
Frederik Barkhof
Frederik Barkhof
VU University Medical Center
Verified email at vumc.nl - Homepage
Title
Cited by
Cited by
Year
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
64692018
Consistent resting-state networks across healthy subjects
JS Damoiseaux, SARB Rombouts, F Barkhof, P Scheltens, CJ Stam, ...
Proceedings of the national academy of sciences 103 (37), 13848-13853, 2006
49692006
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ...
The Lancet Neurology 12 (8), 822-838, 2013
45912013
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS SÝrensen, ...
Neurology 83 (3), 278-286, 2014
36692014
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ...
New England Journal of Medicine 362 (5), 402-415, 2010
27982010
A new rating scale for age-related white matter changes applicable to MRI and CT
LO Wahlund, F Barkhof, F Fazekas, L Bronge, M Augustin, M Sjogren, ...
Stroke 32 (6), 1318-1322, 2001
20612001
Atrophy of medial temporal lobes on MRI in" probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
P Scheltens, D Leys, F Barkhof, D Huglo, HC Weinstein, P Vermersch, ...
Journal of Neurology, Neurosurgery & Psychiatry 55 (10), 967-972, 1992
19161992
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.
F Barkhof, M Filippi, DH Miller, P Scheltens, A Campi, CH Polman, ...
Brain: a journal of neurology 120 (11), 2059-2069, 1997
17931997
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
G Comi, M Filippi, F Barkhof, L Durelli, G Edan, O FernŠndez, HP Hartung, ...
The Lancet 357 (9268), 1576-1582, 2001
14772001
Reduced resting-state brain activity in the “default network” in normal aging
JS Damoiseaux, CF Beckmann, EJS Arigita, F Barkhof, P Scheltens, ...
Cerebral cortex 18 (8), 1856-1864, 2008
14032008
A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging
P Scheltens, F Barkhof, D Leys, JP Pruvo, JJP Nauta, P Vermersch, ...
Journal of the neurological sciences 114 (1), 7-12, 1993
11191993
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ...
The Lancet Neurology 15 (3), 292-303, 2016
10192016
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes
L Kappos, CH Polman, MS Freedman, G Edan, HP Hartung, DH Miller, ...
Neurology 67 (7), 1242-1249, 2006
10142006
Cortical lesions in multiple sclerosis
D Kidd, F Barkhof, R McConnell, PR Algra, IV Allen, T Revesz
Brain 122 (1), 17-26, 1999
9601999
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
TA Yousry, EO Major, C Ryschkewitsch, G Fahle, S Fischer, J Hou, ...
New England Journal of Medicine 354 (9), 924-933, 2006
9482006
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
D Miller, F Barkhof, X Montalban, A Thompson, M Filippi
The Lancet Neurology 4 (5), 281-288, 2005
9392005
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ...
The Lancet 378 (9805), 1779-1787, 2011
9252011
STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and†…
JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ...
Lancet Neurol 12 (8), 822-838, 2013
9222013
Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study
SARB Rombouts, F Barkhof, R Goekoop, CJ Stam, P Scheltens
Human brain mapping 26 (4), 231-239, 2005
9102005
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability
JHTM Van Waesberghe, W Kamphorst, CJA De Groot, ...
Annals of Neurology: Official Journal of the American Neurological†…, 1999
8811999
The system can't perform the operation now. Try again later.
Articles 1–20